Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-05-29

FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate), authorizing changes to the product's labeling. The changes may include updat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viread (tenofovir disoproxil fumarate)

Snippet

SUPPL AP for VIREAD (TENOFOVIR DISOPROXIL FUMARATE)